» Articles » PMID: 39683923

Bioactive Potential of Chitosan-Oleic Acid Nanoparticles Loaded with Lemon Peel Essential Oil for Topical Treatment of Vulvovaginal Candidiasis

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 Dec 17
PMID 39683923
Authors
Affiliations
Soon will be listed here.
Abstract

The rising incidence of vulvovaginal candidiasis (VVC) has been leading to the development of alternative antifungal therapies. This study aimed to develop a topical chitosan-oleic acid nanoparticle (CH-OA-NP) cream loaded with lemon peel essential oil (LPEO) for VVC treatment. The characterization of the optimal nanoparticle formulation (F4: 10 g/L CH, 2:1 OA/LPEO ratio) showed high encapsulation efficiency, stability, and controlled release. Moreover, it was characterized regarding its particle size, polydispersity index, zeta potential, and chemical/morphological profile. LPEO-related compounds (e.g., eriodictyol) were identified through LC-ESI-QqTOF-HRMS in the cream matrix, suggesting the preservation of LPEO potential bioactivities after formulation. In silico docking of 12 LPEO metabolites revealed that compounds such as citronellic acid exerted inhibitory effects against several inflammation-associated enzymes (e.g., 14-α-Demethylase). In vitro antimicrobial tests demonstrated remarkable activity against , Gram-negative (e.g., ), and Gram-positive (e.g., ) bacteria. studies in a rat model of VVC revealed significant antifungal, anti-inflammatory, and immunomodulatory effects of the LPEO-CH-OA-NP cream (5% and 10%), leading to reduced MDA, MPO, and IL-1β levels and increased GSH activity. This novel formulation potentially offers a promising alternative therapy for VVC, addressing the current antifungal therapies' limitations, counteracting drug resistance.

References
1.
Ben Hsouna A, Ben Halima N, Smaoui S, Hamdi N . Citrus lemon essential oil: chemical composition, antioxidant and antimicrobial activities with its preservative effect against Listeria monocytogenes inoculated in minced beef meat. Lipids Health Dis. 2017; 16(1):146. PMC: 5543433. DOI: 10.1186/s12944-017-0487-5. View

2.
Shalaby E, Aboutaleb S, Ismail S, Yassen N, Sedik A . Chitosan tamarind-based nanoparticles as a promising approach for topical application of curcumin intended for burn healing: and study. J Drug Target. 2023; 31(10):1081-1097. DOI: 10.1080/1061186X.2023.2276662. View

3.
Amaral A, Saavedra P, Souza A, de Melo M, Tedesco A, Morais P . Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections. Colloids Surf B Biointerfaces. 2018; 174:409-415. DOI: 10.1016/j.colsurfb.2018.11.048. View

4.
Balakrishnan S, Yamang H, Lorenz M, Chew S, Than L . Role of Vaginal Mucosa, Host Immunity and Microbiota in Vulvovaginal Candidiasis. Pathogens. 2022; 11(6). PMC: 9230866. DOI: 10.3390/pathogens11060618. View

5.
Abd El-Alim S, Salama A, Darwish A . Provesicular elastic carriers of Simvastatin for enhanced wound healing activity: An in-vitro/in-vivo study. Int J Pharm. 2020; 585:119470. DOI: 10.1016/j.ijpharm.2020.119470. View